GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

An announcement from Symphony Limited ( ($IN:SYMPHONY) ) is now available. Symphony Limited announced the sale of technology ...

The benchmark KSE-100 index declined over 1,300 points to close at 114,853. Market activity was overshadowed by broad-based pressure, with heavyweight stocks such as UBL, Fauji Fertiliser Company, ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

CureVac NV (CVAC) reports a robust financial position with a significant licensing agreement with GSK, despite challenges in ...

CureVac (CVAC) has reported its fourth quarter 2024 financial results, generating mixed reactions from investors as the company balances ...

Despite competitive pressures and external risks, Unilever's robust presence in emerging markets and strategic focus on top ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine ...

Nigeria's second-largest pharmaceutical company, GlaxoSmithKline (GSK), announced its exit from the country, ending its 51-year presence.Three months later, Sanofi, another leading pharmaceutical ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and ...